dehydroepiandrosterone has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, X; Feng, P; Guo, Z; Yu, Q | 1 |
| Jiang, Z; Ma, H; Wang, H; Yang, Y; Yao, Y | 1 |
3 other study(ies) available for dehydroepiandrosterone and sirolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Short-term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone-induced polycystic ovary syndrome mice.
Topics: Animals; Dehydroepiandrosterone; Disease Models, Animal; Female; Humans; Mice; Polycystic Ovary Syndrome; Reproduction; Sirolimus; Testosterone | 2021 |
Dehydroepiandrosterone alleviates oleic acid-induced lipid metabolism disorders through activation of AMPK-mTOR signal pathway in primary chicken hepatocytes.
Topics: AMP-Activated Protein Kinases; Animals; Chickens; Dehydroepiandrosterone; Hepatocytes; Lipid Metabolism; Lipid Metabolism Disorders; Mammals; Oleic Acid; RNA, Messenger; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2023 |